Highlight Therapeutics is a clinical-stage biopharmaceutical company.
Highlight Therapeutics has raised €38M across 2 funding rounds from 2 investors, most recently a round in Sep 2025. Based in Paterna, Spain; founded 2010; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2025-09-16 | Other | €15M | Buenavista Equity Partners,Columbus Venture Partners | View deal → |
| 2021-02-04 | Other | €23M | — | View deal → |
